GlobalData Archives - Page 12 of 47 - Express Pharma

ALS market across 8MM set to reach $1.28 bn in 2029: GlobalData

Moderna’s Covid-19/influenza vaccine phase III data highlights potential of mRNA technology for infectious diseases: GlobalData

China leads APAC in institute-led clinical trials: GlobalData

Roche’s Vabysmo showcases stronghold across wAMD and DME spaces : GlobalData

BIOSECURE act forces US pharma to re – evaluate China manufacturing reliance : GlobalData

Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData

Neurology remains key therapeutic area for Japan pharma majors: GlobalData

AbbVie’s immunology portfolio to offset Humira losses: GlobalData

Total prevalent cases of osteoporosis to cross 58.05 mn in 7MM by 2033: GlobalData

Cell and gene manufacturers benefit from surge in FDA drug approvals: GlobalData